Corient Private Wealth
NVS icon

Corient Private Wealth’s Novartis NVS Stock Holding History

Corient Private Wealth’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.5M Sell
437,208
-3,318
-0.8% -$497K 0.09% 192
2026
Q1 		$67.2M Sell
440,526
-39,378
-8% -$6.04M 0.1% 195
2025
Q4 		$66.2M Buy
479,904
+21,364
+5% +$2.8M 0.09% 201
2025
Q3 		$58.8M Buy
458,540
+5,717
+1% +$698K 0.09% 207
2025
Q2 		$54.8M Sell
452,823
-10,257
-2% -$1.16M 0.07% 222
2025
Q1 		$51.6M Sell
463,080
-78,448
-14% -$8.35M 0.08% 216
2024
Q4 		$52.7M Sell
541,528
-38,264
-7% -$4.08M 0.09% 217
2024
Q3 		$66.7M Sell
579,792
-941
-0.2% -$107K 0.1% 194
2024
Q2 		$61.8M Sell
580,733
-5,055
-0.9% -$507K 0.11% 194
2024
Q1 		$56.7M Sell
585,788
-1,775
-0.3% -$182K 0.1% 208
2023
Q4 		$59.3M Buy
587,563
+129,578
+28% +$12.5M 0.11% 190
2023
Q3 		$46.6M Buy
457,985
+3,634
+0.8% +$369K 0.11% 203
2023
Q2 		$45.8M Buy
454,351
+50,920
+13% +$5.09M 0.11% 202
2023
Q1 		$37.1M Buy
403,431
+146,545
+57% +$12.8M 0.1% 198
2022
Q4 		$23.3M Buy
+256,886
New +$21.6M 0.08% 247

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Corient Private Wealth's NVS Position: Q2 2026 in Review

Corient Private Wealth reduced its Novartis (NVS) stake by 0.75% in Q2 2026, selling an estimated $497K and leaving 437,208 shares worth $68.5M. The position accounts for 0.09% of the portfolio, ranked #192.

Corient Private Wealth first reported a position in NVS in Q4 2022 and has held it in 15 quarters since. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Corient Private Wealth held 437,208 shares of Novartis worth $68.5M as of Q2 2026.
  • Corient Private Wealth sold 3,318 Novartis shares in Q2 2026, an estimated $497K.
  • Novartis made up 0.09% of Corient Private Wealth's portfolio in Q2 2026, its #192 holding.
  • Corient Private Wealth first reported a position in Novartis in Q4 2022 and has held it in 15 quarters since.
  • 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.